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Abstract
Polyphenols have beneficial effects on several chronic diseases but assessing polyphenols intake 
from self-reported dietary questionnaires tends to be inaccurate and not very reliable. A promising 
alternative is to use urinary excretion of polyphenols as a proxy measure of intake. The best 
method to assess urinary excretion is to collect 24-h urine. However, since collecting 24-h urine 
method is expensive, time consuming and may be difficult to implement in large population-based 
studies, measures obtained from spot urine normalized by creatinine are commonly used. The 
purpose of the study was to evaluate the correlation between polyphenols dietary intake and total 
urinary polyphenol excretion (TPE), expressed by both 24-h volume and urinary creatinine 
normalization in 928 participants from the InCHIANTI study. Dietary intake data were collected 
using a validated food frequency questionnaire. Urinary TPE was analyzed by Folin–Ciocalteau 
assay. Both urinary TPE expression models were statistically correlated (r = 0.580), and the partial 
correlation coefficient improved (pr = 0.722) after adjusting for the variables that modify the 
urinary creatinine excretion (i.e. gender, age, BMI, physical activity and renal function). In crude 
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models, polyphenol intake was associated with TPE corrected by 24-h volume (r = 0.211; P < 
0.001), but not with creatinine normalization (r = 0.014; P = 0.692). However, urinary TPE 
expressed by creatinine correction was significantly correlated with dietary polyphenols after 
adjusting for covariates (pr = 0.113; P = 0.002). We conclude that urinary TPE expressed by 24-h 
volume is a better biomarker of polyphenol dietary intake than by urinary creatinine 
normalization. After covariate adjustment, both can be used for studying the relationships between 
polyphenol intake and health in large-scale epidemiological studies.
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1. Introduction
Polyphenols are widespread, naturally occurring, secondary plant compounds, with more 
than 8000 different phenolic structures currently identified [1]. Both clinical and 
epidemiological studies provide evidence that polyphenol-rich foods and polyphenol-rich 
diet have protective effects against chronic diseases such as cancer, obesity cardiovascular 
and neurodegenerative diseases. These beneficial effects are due to their antioxidant, 
antiviral, anti-inflammatory and chemopreventive activities [2,3].
There are, however, a number of limitations related to studies concerning the beneficial 
effects of polyphenols. First, it is very difficult to assess dietary exposure to polyphenols 
because dietary data are usually obtained by means of food frequency questionnaires 
(FFQs), which provide inaccurate information [4]. Moreover, information on total 
polyphenol content is extremely limited. There are some food composition data using the 
global Folin–Ciocalteau (F–C) assay, although a lower amount of data is available using 
more specific and accurate techniques (such as HPLC and GC coupled with DAD or MS 
detectors) [5–7]. Finally, nutritional status also depends on the absorption and metabolism of 
polyphenols, the bioavailability of which differs enormously from one molecule to another 
[8] and among individuals [9]. These problems could be solved using a biomarker as a 
reliable proxy measure of polyphenol consumption [10].
Specific polyphenols and flavonoids that can be quantified by LC–MS/MS are promising 
biomarkers for the intake of fruits and vegetables [11,12], polyphenol-rich beverages [13] 
and polyphenol-rich foods consumption [14]. Currently, F–C assay in urine samples is 
considered the best biomarker for total polyphenol intake [15–18]. The F–C method, with a 
previous solid-phase extraction, is a rapid and global measure of total polyphenol content. 
This methodology has been optimized to apply to large-scale epidemiological studies 
because it is quick and economic [15].
The urine sample when expressed by volume (24-h) is considered to be the most reliable and 
non-invasive biological specimen for assessing polyphenol biomarkers [10]. However, its 
collection is tedious for both patients and researchers. When total volume in 24 h is not 
available, the normalization of urine samples can be performed in different ways, such as by 
urinary creatinine (creatinuria), specific gravity or osmolarity, although creatinine is the 
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most usual correction method [15,19] and provides results that are better than, or at least as 
good as, the others [20,21]. To date, the F–C assay has only been used in large studies using 
urine normalized by creatinine [15,22], although there are some small nutritional studies on 
polyphenol excretion that show relevant between estimates obtained by urinary creatinine or 
24-h urine volume normalization [23]. Using data from a large, population-based survey, the 
aim of this study was to assess the correlation between measures of polyphenolic content by 
the F–C assay expressed by 24-h volume or by urinary creatinine correction. In addition, we 
also studied the correlation of both measures with self-reported measures of dietary intake.
2. Methods
2.1. Population
The InCHIANTI (Invecchiare in Chianti) study (www.inchiantistudy.net) is a prospective 
cohort investigation aimed at assessing factors affecting loss of mobility in later life. The 
study design and data collection have been described elsewhere [24]. Briefly, 1453 
predominantly elderly subjects were randomly selected from the populations of Greve in 
Chianti and Bagno a Ripoli, two small towns located in the Chianti countryside of Tuscany, 
Italy. Of these, 928 participants, who had both dietary assessment data and biological 
samples, were available and were included in the present study. The participants were all 
European and of Caucasian race. The Italian National Institute of Research and Care on 
Aging Ethical Committee approved the study protocol, and written informed consent was 
obtained from each participant.
2.2. Dietary and physical activity assessment
At baseline, usual food and energy intake were estimated through personal interviews using 
the Italian version of the FFQ developed and validated in the European Prospective Study 
into Cancer and Nutrition (EPIC) study [25]. Total dietary polyphenols were calculated 
according to Ovaskainen et al. [7]. These total polyphenol data (expressed as mg/100 g) 
were aggregated from phenolic acids, flavonoids (anthocyanidins, flavan-3-ols, 
proanthocyanidins, flavanones, flavones, flavonols and isoflavones), lignans and 
ellagitannins, which were analyzed by HPLC [7]. For several food items, values were 
completed using data from US Department of Agricultural databases [6,26] and Phenol-
Explorer [5].
The level of physical activity in the year prior to the interview was classified on an ordinal 
scale, based on responses to a modified standard questionnaire [27], into: (1) hardly any 
physical activity; (2) mostly sitting/some walking; (3) light exercise 2–4 h/week; (4) r light 
>4 h/week or moderate 1–2 h exercise; (5) moderate exercise >3 h/week; (6) intense exercise 
many times/week; and (7) walks >5 km day−1, >5 days/week, >5 years.
2.3. Standards and reagents
All samples and standards were handled with no exposure to light. F–C reagent, boric acid 
99.5% and gallic acid were obtained from Sigma®, and sodium carbonate from Panreac. 
Anhydrous sodium acetate, concentrated hydrochloric acid, methanol, acetic acid 99.8% and 
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formic acid 98–100% were purchased from Scharlau, and ultrapure water (Milli-Q) from 
Millipore (Bedford, MA).
2.4. Analytical methods
Twenty-four hour urine samples were collected from all participants. Urine samples were 
coded, boric acid was added as a preservative, and the samples were then stored at −80 °C 
until analysis. The clinical investigators and laboratory technicians were not provided with 
clinical data. Total urinary polyphenol was analyzed by F–C assay, after a solid-phase clean-
up as described elsewhere [15]. Urine samples were centrifuged for 10 min at 4 °C, and 800 
µL of supernatants were diluted with 800 µL of Milli-Q water and acidified with 34 µL of 
concentrated hydrochloric acid. After equilibrating the cartridges (Oasis® MAX 60 mg, 
Waters, Milford, MA, USA), 800 µL of urine was loaded. The cartridges were washed with 
1 mL of sodium acetate 50 mM (pH 7) in 5% of methanol. Then, polyphenols were eluted 
with 1800 µL of 2% formic acid in methanol. 15 µL of the eluted fractions were mixed with 
170 µL of Milli-Q water in the thermo microtiter 96-well plate (nunc™, Roskilde, 
Denmark), and 12 µL of F–C reagent and 30 µL of sodium carbonate (200 g L−1) were 
added. The mixtures were incubated for 1 h at room temperature in the dark. After the 
reaction period, 73 µL of Milli-Q water were added, and finally absorbance was measured at 
765 nm in a UV–vis Thermo Multiskan Spectrum spectrophotometer (Vantaa, Finland). 
Total polyphenol equivalents (TPEs) were expressed as mg gallic acid equivalent (GAE)/24-
h urine or mg GAE/g of creatinine.
Urinary creatinine was measured using a compensated modified Jaffe kinetic method for a 
Roche/Hitachi analyzer (Roche Diagnostics GmbH, Mannheim, Germany) [28].
Renal function was calculated by Cockcroft–Gault equation: (140 − age) × weight × 0.85 (if 
female)/(serum creatinine × 72). All participants were classified as having normal renal 
function (equal or higher than 60 mL min−1), impaired renal function (≥30 to < 60 mL 
min−1), profoundly impaired renal function or renal failure (lower than 30 mL min−1).
2.5. Statistical analysis
All analyses were performed using SPSS software version 15.0 (SPSS Inc., Chicago, IL, 
USA). Baseline characteristics of the participants were expressed as means (SD) for normal 
distribution or percentages. Skewed variables (Kolmogorov with the Lilliefors Significance 
correction and Levene tests) were described as median (interquartile range). Total dietary 
polyphenol was normalized by natural logarithm for further analysis. Variables such as urine 
TPE, which were not normalized by the logarithmic transformation, were Box–Cox 
transformed with α = 0.00001 and λ = 0.15. Pearson correlation and the partial correlation 
coefficient in a multiple linear regression model with transformed urine TPE (expressed as 
mg GAE/24-h urine) as a dependent variable, and transformed urine TPE (expressed as mg 
GAE/g of urinary creatinine) as an independent variable, as well as age, sex, BMI, physical 
activity, energy intake (expressed as 1000 kcal day−1) and renal function (normal, impaired, 
and profoundly impaired or failure) as covariates, were calculated to estimate the association 
between both expression types of transformed urine TPE. The association between 
transformed total dietary polyphenols and crude urine TPE (expressed as 100 mg GAE/24-h 
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urine or as 100 mg GAE/g of urinary creatinine) was assessed by multiple linear regressions 
(partial correlation coefficient), adjusting for gender, age, BMI, physical activity, energy 
intake (expressed as 1000 kcal day−1), and renal function. In the last models, urinary TPEs 
were expressed as 100 mg GAE because the B-coefficients were very low. The difference 
between both correlation coefficients of transformed total dietary polyphenols and crude 
urine TPE models was assessed using the Hotelling’s t-test for dependent correlations within 
a population. All the regression models were tested for the detection of outliers, 
multicollinearity, homoscedasticity, and the normality and independence of errors. All 
statistical tests were two-tailed, and the significance level was P < 0.05.
3. Results
The participant characteristics stratified by urinary creatinine quartiles are summarized in 
Table 1. The mean age was about 70 years, 55.3% or the participants were women and 
56.4% had impaired renal function.
Urinary TPE expressed by 24-h volume and by urinary creatinine correction were highly 
correlated (r = 0.580; P < 0.001). A partial correlation coefficient in the multiple linear 
regression model confirmed this association (pr = 0.722; P < 0.001), showing, in addition, 
that gender, age, physical activity, energy intake and renal function were also significantly 
associated, but BMI was not (Table 2).
The estimated dietary polyphenol intake from validated FFQs was correlated directly in a 
raw model with urinary TPE expressed by 24-h volume (r = 0.211; P < 0.001), but it was not 
correlated with urinary creatinine-corrected TPE (r = 0.014; P = 0.692). However, in 
multiple linear models the association between dietary polyphenol and both transformed 
TPE expressions was statistically significant (partial correlation coefficient (pr) = 0.164; P < 
0.001 for24-h volume; and pr = 0.113; P = 0.002 for urinary creatinine correction, 
respectively), after adjusting for gender, age, BMI, physical activity, energy intake and renal 
function (Table 3). In both models the significant covariates were gender, age, physical 
activity and energy intake, but not BMI and renal function. The Hotelling’s t-test showed 
statistically significant differences between correlation coefficients of both models (P < 
0.001).
4. Discussion
In the current study, we observed a significant correlation between urinary TPE expressed as 
24-h volume and as normalized by urinary creatinine, in an elderly free-living population. 
The correlation was considerably higher after adjusting for age, gender, physical activity, 
energy intake and renal function. We also show that both urinary TPE measures were 
statistically associated with total polyphenol intake.
As expected, urinary TPE 24-h volume is the best method to quantify polyphenol 
biomarkers urinary excretion as it was best correlate with intake. However, 24-h urine 
collection it is not practical in large-scale epidemiological studies [4,10]. Our findings 
suggest that normalizing TPE with urinary creatinine provides a good measurement 
alternative to 24-h urine collection [15], as long as such values are used in analyses that 
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account for covariates that can modify creatinine excretion. Renal function is obviously 
important because creatinine is the most commonly used indicator of renal function [29]; in 
this study, subjects with renal failure or renal impairment were classified in lower urinary 
creatinine quartiles than normal subjects (P of trend < 0.001). Gender, age and race are 
covariates that affect creatinine excretion and clearance rate [30,31]; men produced more 
creatinine than women – mean (SD) 89.7 (39.8) and 61.7 (29.2) mg dL−1, respectively – 
which may be due, in part, to their higher muscular mass. Moreover, there was also a 
negative significant correlation between age and creatinine excretion (r = −0.234, P < 0.001). 
Although ethnic group is an important covariate, this was not included in the regression 
model because all subjects in the cohort were Caucasian, and the effect of race should be 
evaluated in future studies. Diet, assessed as energy intake (r = 0.283; P < 0.001), physical 
activity (r = 0.268; P < 0.001) and BMI (r = 0.081; P = 0.021) were also statistically 
correlated with urinary creatinine. That is because creatinine is a by-product of muscle 
catabolism, so its production is expected to depend on body composition, exercise and food 
patterns [21,32]. Indeed, the importance of all these variables, with the exception of BMI, 
was also shown when they were included in the regression model between both urinary TPE, 
as the partial correlation coefficient improved from 0.580 to 0.722.
The secondary aim of the current study was to assess both urinary TPE measures as 
biomarkers of total polyphenol intake. We found a significant crude correlation between 
urinary TPE expressed as mg GAE/24-h volume and total polyphenol intake (r = 0.211; P < 
0.001. However, TPE expressed as mg GAE/g creatinine and total polyphenol intake were 
not significantly correlated. In part, these differences could be due to the high variability of 
creatinine excretion, depending on gender, age, physical activity, renal function and diet. 
Our Pearson correlation coefficient was lower than that published by our group in other 
studies using urine creatinine normalization [15,22]. However, these differences could be 
explained in part because the InCHIANTI population is older and has more renal 
dysfunction than the populations recruited in the other studies. Moreover, these differences 
could also be due to dietary polyphenol quantification, because in the current study, food 
composition data came from HPLC analysis, while in the other studies food data were 
analyzed by F–C assay. Composition data on total polyphenol using F–C could be 
overestimated if one does not take into account or eliminate the interfering substances that 
can react with the F–C reagent. In our study, this is solved by using a cleanup before the F–C 
assay to eliminate interfering substances, such as sulfur dioxide, ascorbic acid, sugar, 
aromatic amines, organic acid, and Fe(II) [16].
Covariate adjustments in urinary TPE expressed by creatinine correction model increased 
the partial regression coefficient with dietary intake, which became statistically significant 
(pr = 0.116; P = 0.002). The fit of the model in which urinary TPE was expressed as 24-h 
volume remained significantly better than the fit for TPE urinary creatinine normalized 
model.
Interestingly, renal function is not a significant covariate in models including urinary TPE 
expressed by 24-h volume because renal function can vary the total urinary volume excreted, 
but it would not alter the ratio between 24-h TPE and urinary 24-h volume. However, renal 
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function would be a significant variable in models in which TPE was corrected by urinary 
creatinine, because creatinine excretion varies with renal function [29].
Polyphenol biomarkers measured in urine normalized by 24-h volume usually show higher 
regression coefficients than when creatinine correction is applied; for instance, 24-h urinary 
levels of alkylresorcinols and isoflavones as biomarkers of cereal fiber intake (r = 0.40) and 
soy (r = 0.52) intakes, respectively, versus urinary creatinine normalized levels of 4-O-
methylgallic acid and isoferulic acid as biomarkers of tea (r = 0.50) and coffee (r = 0.26) 
intakes, respectively [33–35]. For other urinary biomarkers, using creatinine correction, for 
example for resveratrol metabolites as a biomarker of wine consumption, provides high 
regression coefficients (r = 0.89) [19,36]. The main limitation of the study may be the use of 
an FFQ, because it is not the best dietary assessment technique [37], although this FFQ has 
been validated for this population and the EPIC Italian population [38]. Moreover, in EPIC – 
Europe, this FFQ was also used to positively correlate plasma carotenoids and fruit and 
vegetable consumption [39], and fruits and vegetables are the second main polyphenol 
source, after coffee, in the Finnish population [7]. For this reason, we consider this FFQ 
suitable for assessing polyphenol intake. Another drawback may be that the participants of 
the study were older subjects and there was a high prevalence of renal impairment, thus the 
results cannot probably be extrapolated to the general population. In this case, when we 
compare the same analytical measure (TPE) expressed in two different ways (by 24-h 
volume and by urinary creatinine correction) renal function is statistically significant. 
However, when we have an analytical variable (urinary TPE) and a dietary variable (total 
dietary polyphenols) which was assessed with more error than analytical ones [40], renal 
function is not significant, although in a homogenous population, as with the men in the 
current study, renal function was of borderline significance
In conclusion, we showed that urinary TPE expressed in both 24-h volume and by urinary 
creatinine correction are highly correlated, especially after adjusting for covariates. 
Furthermore, our data support that urinary TPE expressed by 24-h volume is a better 
biomarker of polyphenol dietary intake than by urinary creatinine normalization, although 
creatinine-corrected urinary TPE adjusted for covariates may also be a suitable biomarker of 
total polyphenol in a free-living population. For these reasons, the biomarker, expressed by 
24-h volume and by urinary creatinine correction, would be an additional and more reliable 
tool for studying the relationships between polyphenol intake and health effects in large 
epidemiological studies.
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Table 2
Multiple linear regression model explaining the association between transformed urine TPE expressed as mg 
GAE/24-h urine (as dependent variable) and transformed urine TPE expressed as mg GAE/g of urinary 
creatinine (as independent variable), after adjusting for covariates.
B-coefficients (IC 95%) P-value
Constant of the model 3.628 (2.978 to 4.279) <0.001
Transformed urinary TPE (mg GAE/g of creatinine) 0.693 (0.646 to 0.740) <0.001
Gender (female vs. male) −0.452 (−0.552 to −0.352) <0.001
Age (per year) −0.015 (−0.019 to −0.010) <0.001
BMI (kg m−2) −0.001 (−0.012 to 0.009) 0.786
Physical activity 0.085 (0.034 to 0.136) 0.001
Energy intake (1000 kcal day−1) 0.084 (0.002 to 0.166) 0.045
Renal function
  Impaired vs. normal −0.207 (−0.307 to −0.106) <0.001
  Profoundly impaired or failure vs. normal −0.612 (−0.971 to −0.254) 0.001
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Table 3
Results from multiple linear regression analysis which assessed the association between transformed total 
dietary polyphenols and transformed urine TPE expressed as 100 mg GAE/24-h urine (model 1) and expressed 
as 100 mg GAE/g urinary creatinine (model 2), after adjusting for covariates.
Model 1 (expressed by 24-h volume) Model 2 (expressed by creatinine)
B-coefficients (IC 95%) P-value B-coefficients (IC 95%) P-value
Constant of the model 5.170 (4.896 to 5.445) <0.001 5.297 (5.028 to 5.565) <0.001
Crude urine TPE 0.072 (0.042 to 0.103) <0.001 0.030 (0.012 to 0.049) 0.002
Gender (female vs. male) 0.085 (−0.131 to −0.039) <0.001 −0.103 (−0.149 to −0.056) <0.001
Age (per year) 0.003 (0.001 to 0.005) 0.002 0.002 (0.001 to 0.004) 0.013
BMI (kg m−2) −0.002 (−0.007 to 0.003) 0.483 −0.002 (−0.007 to 0.003) 0.431
Physical activity 0.027 (0.003 to 0.051) 0.025 0.031 (0.007 to 0.055) 0.012
Energy intake (1000 kcal day−1) 0.344 (0.305 to 0.382) <0.001 0.346 (0.308 to 0.385) <0.001
Renal function
  Impaired vs. normal −0.023 (−0.070 to 0.025) 0.347 −0.034 (−0.081 to 0.014) 0.161
  Profoundly impaired or failure vs. normal −0.014 (−0.182 to 0.154) 0.868 −0.045 (−0.214 to 0.124) 0.600
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